Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections work by activating GLP-1 receptors in your brain and digestive system, but only if the medication reaches subcutaneous tissue successfully. Many patients wonder whether their weekly shot actually penetrated the skin and delivered the full dose, especially during their first few attempts. Understanding the signs of a properly administered injection helps you build confidence in your treatment routine.

Physical Signs Your Semaglutide Injection Entered the Skin

A successful semaglutide injection produces immediate tactile feedback that confirms needle penetration. You should feel a slight pop or give when the needle passes through the skin layer and enters the subcutaneous fat beneath. This sensation typically lasts less than one second and is distinctly different from the resistance you feel when the needle first touches your skin. Most patients describe it as a brief clicking feeling followed by reduced pressure as the needle continues its path.

After the needle enters, pushing the plunger should require steady, moderate pressure without excessive resistance. If the plunger feels extremely hard to depress, the needle may be in muscle rather than fat, or it may not have fully penetrated the skin at all. Conversely, if the plunger moves too easily, you may have injected into the wrong tissue layer. The ideal injection takes approximately five to ten seconds to complete and should feel smooth and controlled throughout the process.

Observe whether a small amount of liquid appears on your skin after withdrawal. This does not necessarily mean your injection failed—semaglutide is highly viscous and sometimes a tiny bead forms at the injection site. However, if blood or a stream of liquid follows the needle out, the injection likely entered a blood vessel or superficial layer rather than subcutaneous tissue, and you should contact your healthcare provider about proper technique at your next appointment.

Timeline of Absorption: When Does Semaglutide Start Working?

Semaglutide absorption begins within minutes of a properly placed subcutaneous injection, with peak plasma concentrations occurring between 24 and 48 hours afterward. Your body's lymphatic system picks up the medication from the injection site and gradually distributes it into the bloodstream, where it can reach GLP-1 receptors throughout your body. This delayed peak explains why you may not notice appetite suppression or nausea on injection day itself—most patients experience the strongest effects on days two through four after their weekly shot.

Within the first two to four hours after injection, you may notice a subtle fullness sensation even if you haven't eaten, which indicates that semaglutide is beginning to activate satiety pathways in your hypothalamus. By the next morning, most people report decreased hunger at breakfast, which is one of the most reliable early signs that the medication has been properly absorbed. If you feel absolutely no change in appetite or satiety within 24 hours of injection, it may be worth consulting your provider about injection technique or the possibility of a needle that didn't fully penetrate.

Peak appetite suppression typically occurs 48 to 72 hours post-injection, and this window is when you'll experience maximum reduction in food cravings and portion sizes. Some patients feel mild nausea during this peak absorption phase, which is not a sign of improper injection but rather evidence that the medication is working systemically. This delayed timeline is also why missing a weekly injection dose creates a noticeable gap in appetite control—the medication's effects wear off gradually over seven days, requiring consistent weekly dosing.

Signs Your Injection May Have Missed the Target

If you experience sharp, shooting pain during or immediately after injection, the needle likely hit a nerve or blood vessel rather than subcutaneous fat. This differs from the mild pressure or pinching sensation that normally accompanies needle penetration. Nerve contact usually causes pain that radiates or tingles for several seconds after withdrawal, while hitting a blood vessel may cause blood to back up into the syringe or form a visible hematoma (bruise) within minutes. Contact your provider if this occurs, as future injections should target a different location on your body.

An injection that does not take hold typically produces zero appetite-suppressing effects by 24 hours post-administration. Unlike the gradual onset that characterizes proper absorption, a missed injection leaves your hunger levels and portion control unchanged compared to the day before. Additionally, if you notice swelling, redness, or warmth that develops within hours rather than days, the needle may have entered muscle tissue or triggered a localized inflammatory response. These symptoms usually resolve within 48 hours but warrant a technique adjustment at your next injection.

Leakage back through the injection site immediately after needle withdrawal is another indicator that the needle did not fully penetrate. If you see the plunger still moving backward or medication pooling on the skin's surface, some or all of the dose may not have been delivered. This is particularly common when patients inject too quickly or use too shallow an angle. Proper subcutaneous technique requires inserting the needle at a 45 to 90-degree angle and waiting two to three seconds after plunging before slowly withdrawing the needle to allow medication to distribute into tissue.

Confirming Medication Delivery Through Clinical Response and Testing

PlexusDx recommends tracking your weekly appetite and weight loss over the first month to objectively confirm that your semaglutide injection is working as expected. Most patients lose one to two pounds per week during the initial four weeks if their injections are being properly administered and absorbed. Keep a simple log of your hunger levels each morning and evening, noting any reduction compared to your baseline before starting treatment. By week three or four, you should detect a clear pattern of decreased cravings, smaller portion sizes, or spontaneous skipping of meals you would normally eat.

If you're not seeing the expected appetite suppression or weight loss after four weeks of correctly administered injections, PlexusDx offers the Precision Peptide Genetic Test to identify whether genetic variants in your GLP1R pathway or other appetite-regulation genes may explain a slower initial response. This peptide-pathway genetic assessment maps 14 signaling pathways and 49 peptides involved in weight regulation, revealing whether you have genetic predispositions that require dose optimization or supplementary compounds like tirzepatide. Understanding your genetic peptide profile helps your provider confirm that injections are delivering medication into the right tissue and that your body's receptors are responding appropriately.

Your healthcare provider can also assess injection technique during follow-up visits by observing your injection method or examining injection sites for signs of repeated shallow placement or improper angles. Proper subcutaneous injection sites—typically the abdomen or thigh—should show minimal bruising and no signs of infection or tissue irritation beyond normal post-injection redness lasting a few hours. If multiple injection sites show persistent swelling, scarring, or hardened areas, your technique may need adjustment, or your provider may recommend rotating sites more frequently to allow tissue recovery.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How can I tell if my semaglutide injection went into the right layer of tissue?

A properly placed injection should produce a brief pop or click as the needle enters subcutaneous fat, followed by smooth plunger resistance and no significant blood or fluid leakage upon withdrawal. Most patients experience reduced appetite within 24 hours if the injection was successful. If you feel sharp radiating pain, see blood backup into the syringe, or notice zero appetite changes by the next morning, the needle likely entered muscle or missed the subcutaneous layer—contact your provider about technique adjustments.

Why do I feel nothing after my semaglutide injection on the first day?

Semaglutide requires 24 to 48 hours to reach peak blood levels and activate GLP-1 receptors throughout your body, so appetite suppression typically begins on day two rather than day one. The injection may have gone in perfectly even if you feel no immediate hunger reduction. Monitor your appetite on days two through four post-injection; most patients notice clear appetite suppression during this window if their injection was properly administered and absorbed.

What is the cost of semaglutide injections through PlexusDx, and does pricing change with dose?

PlexusDx compounded semaglutide injections start at $149 per month and are available through three commitment tiers. Your dose may need to go up as you progress in treatment, but your price won't—PlexusDx maintains flat monthly pricing regardless of dose adjustments. All medications come from licensed 503A compounding pharmacies, require no insurance or membership, and are HSA/FSA eligible.

Could a poor injection technique prevent the medication from working even if the needle went in?

Yes—injecting too quickly, using an improper angle (less than 45 degrees), or withdrawing the needle immediately after pushing the plunger can allow medication to leak back through the injection tract. Proper technique requires inserting the needle at 45 to 90 degrees, holding steady for two to three seconds after the plunger is fully depressed, and then slowly withdrawing. Poor technique may deliver only partial dose even if the needle penetrated skin, resulting in reduced appetite suppression compared to properly administered injections.

How does the PlexusDx Precision Peptide Genetic Test help explain semaglutide response?

The Precision Peptide Genetic Test ($99 add-on after first month) identifies genetic variants in your GLP1R pathway and other appetite-regulation genes that influence how quickly and strongly you respond to semaglutide. If you're experiencing weak appetite suppression despite proper injection technique, genetic testing can reveal whether variants in your GLP1R rs6923761 or other key peptide pathways require dose optimization, supplementary compounds, or an alternative therapy approach for better outcomes.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

learn